In NPM1-mutated AML, which is often associated with low CD34 expression, studies have shown that some cases harbor LSCs exclusively within the CD34− fraction, while others contain LSCs in both the CD34+ and CD34− fractions (Taussig et al., 2010; Quek et al., 2016). This evidence concerns the gene CD34 and acute myeloid leukemia.